Francis Michon - Concepedia

Author

Francis Michon

National Research Council Canada

Also Known As

F Michon, F. Michon, Francis MICHON, Francis Michon, Michon, F.

Publications

3.1K

Citations

H-Index

Concepts

All Affiliations

National Research Council Canada Brigham and Women's Hospital Harvard University Institute for Biological Sciences Saskatchewan Disease Control Laboratory

About

Francis Michon is an author at National Research Council Canada specializing in medicine, microbiology, and glycobiology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	26	36	1.9K
2	Biochemistry	15	16	677
3	Natural Sciences	6	6	276
4	Allergy	5	5	305
5	Engineering	2	2	69

Francis Michon

Publications

Citations

H-Index

Page 1

	Year	Citations
Immunogenicity in animals of a polysaccharide-protein conjugate vaccine against type III group B Streptococcus. Michael R. Wessels, Lawrence C. Paoletti, Dennis L. Kasper, Journal of Clinical Investigation Polysaccharide-protein Conjugate VaccineHumoral ResponseImmunologyGlycobiologyPolysaccharide	1990	191
Group A Streptococcus (GAS) Carbohydrate as an Immunogen for Protection against GAS Infection Hemant Sabharwal, Francis Michon, Daniel Nelson, The Journal of Infectious Diseases Medical MicrobiologyMicrobial DiseaseAutoimmune DiseaseAllergyMedicine	2005	141
Determinant specificities of the groups B and C polysaccharides of <i>Neisseria meningitidis</i>. Harold J. Jennings, R. S. Roy, Francis Michon The Journal of Immunology	1985	123
Conformational differences between linear .alpha.(2.fwdarw.8)-linked homosialooligosaccharides and the epitope of the group B meningococcal polysaccharide Francis Michon, Jean Robert Brisson, Harold J. Jennings Biochemistry Conformational DifferencesBiochemistryNatural SciencesGlycobiologyChemical Shifts	1987	118
Structure of the L2 lipopolysaccharide core oligosaccharides of Neisseria meningitidis. Andrzej Gamian, Michel Beurret, Francis Michon, Journal of Biological Chemistry	1992	113
Safety and immunogenicity of a new Neisseria meningitidis serogroup C-tetanus toxoid conjugate vaccine in healthy adults Peter Richmond, David Goldblatt, Peter C. Fusco, Vaccine VaccinationVaccine SafetyVaccine DevelopmentImmunologyNew Neisseria Meningitidis	1999	100
Stimulation of protective antibodies against type Ia and Ib group B streptococci by a type Ia polysaccharide-tetanus toxoid conjugate vaccine Michael R. Wessels, Lawrence C. Paoletti, A K Rodewald, Infection and Immunity Humoral ResponseImmunologyImmunodominanceCross-protectionProtective Antibodies	1993	100
Structure of the sialylated L3 lipopolysaccharide of Neisseria meningitidis Viliam Pavliak, Jean‐Robert Brisson, Francis Michon, Journal of Biological Chemistry	1993	95
Preclinical Evaluation of a Novel Group B Meningococcal Conjugate Vaccine that Elicits Bactericidal Activity in both Mice and Nonhuman Primates Peter C. Fusco, Francis Michon, J Y Tai, The Journal of Infectious Diseases	1997	90
Structure, conformation and immunology of sialic acid-containing polysaccharides of human pathogenic bacteria Harold J. Jennings, Ewa Katzenellenbogen, Francis Michon, Pure and Applied Chemistry Human Pathogenic BacteriaSialic Acid-containing PolysaccharidesVirulence FactorGlycobiologyPathogen Characterization	1984	83

Page 1